| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |